Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study

NCT04612179 · clinicaltrials.gov ↗
COMPLETED
Status
2017
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

IHF GmbH - Institut für Herzinfarktforschung